I like that news also, including the sucession plan announced today as well:
biz.yahoo.com
Wednesday May 30, 1:30 pm Eastern Time
Kos Pharmaceuticals sets up succession plan
MIAMI, Fla., May 30 (Reuters) - Kos Pharmaceuticals Inc. (Nasdaq:KOSP - news) said on Wednesday that it has set up a succession plan by naming Adrian Adams as president and chief operating officer. Adams will then succeed Daniel Bell as chief executive within a year.
Adams is joining the company on June 11 from Novartis AG , where he was president and chief executive of Novartis Pharmaceuticals UK.
Bell, co-founder and current president and chief executive of Kos, will become chairman of the board and continue as chief executive until next June, Kos Pharmaceuticals said.
Michael Jaharis, co-founder and current Chairman, will become Chairman Emeritus.
Since Kos Pharmaceutical was founded in 1988, Bell has served as the company's chief executive officer and Jaharis, who is the company's largest shareholder, has been chairman. Both will continue on the board and remain active in the company's business after the management succession is completed, Kos said.
BJ |
